NCT04676178View on ClinicalTrials.gov

A Study of PRA023 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

69

Participants

Timeline

Start Date

December 15, 2020

Primary Completion Date

September 23, 2021

Study Completion Date

September 23, 2021

Conditions

Healthy

Interventions

DRUG

PRA023

PRA023

OTHER

Placebo

Placebo

Trial Locations (1)

68502

Celerion, Lincoln

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Celerion

INDUSTRY

lead

Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

INDUSTRY